+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Non-Hodgkin Lymphoma Market and Competitive Landscape - 2020

  • ID: 5023476
  • Report
  • April 2020
  • Region: Global
  • Fore Pharma
1 of 2
The research report Global Non-Hodgkin Lymphoma Market and Competitive Landscape - 2020, provides comprehensive insights into the Non-Hodgkin Lymphoma pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Non-Hodgkin Lymphoma market size and drug sales. It also provides insights into Non-Hodgkin Lymphoma epidemiology and late stage pipeline.

This research covers the following: Non-Hodgkin Lymphoma treatment options, Non-Hodgkin Lymphoma late stage clinical trials pipeline, Non-Hodgkin Lymphoma prevalence by countries, Non-Hodgkin Lymphoma market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:
  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
  • Non-Hodgkin Lymphoma pipeline: Find out drugs in clinical trials for the treatment of Non-Hodgkin Lymphoma by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Non-Hodgkin Lymphoma epidemiology: Find out the number of patients diagnosed (prevalence) with Non-Hodgkin Lymphoma by countries
  • Non-Hodgkin Lymphoma drugs: Identify key drugs marketed and prescribed for Non-Hodgkin Lymphoma in the US, including trade name, molecule name, and company
  • Non-Hodgkin Lymphoma drugs sales: Find out the sales value for Non-Hodgkin Lymphoma drugs by countries
  • Non-Hodgkin Lymphoma market valuations: Find out the market size for Non-Hodgkin Lymphoma drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Non-Hodgkin Lymphoma drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Non-Hodgkin Lymphoma drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Non-Hodgkin Lymphoma market
  • Develop in-depth knowledge of competition and markets
  • Analyze Non-Hodgkin Lymphoma drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Non-Hodgkin Lymphoma market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Non-Hodgkin Lymphoma Treatment Options

2. Non-Hodgkin Lymphoma Pipeline Insights
2.1. Non-Hodgkin Lymphoma Phase 3 Clinical Trials
2.2. Non-Hodgkin Lymphoma Phase 2 Clinical Trials
2.3. Non-Hodgkin Lymphoma Phase 1 Clinical Trials

3. Non-Hodgkin Lymphoma Epidemiology Analysis by Countries

4. US Non-Hodgkin Lymphoma Market Insights
4.1. Marketed Drugs for Non-Hodgkin Lymphoma in US
4.2. US Non-Hodgkin Lymphoma Market Size & Forecast
4.3. US Non-Hodgkin Lymphoma Drugs Sales & Forecast
4.4. US Non-Hodgkin Lymphoma Market Share Analysis

5. Germany Non-Hodgkin Lymphoma Market Insights
5.1. Marketed Drugs for Non-Hodgkin Lymphoma in Germany
5.2. Germany Non-Hodgkin Lymphoma Market Size & Forecast
5.3. Germany Non-Hodgkin Lymphoma Drugs Sales Forecast
5.4. Germany Non-Hodgkin Lymphoma Market Share Analysis

6. France Non-Hodgkin Lymphoma Market Insights
6.1. Marketed Drugs for Non-Hodgkin Lymphoma in France
6.2. France Non-Hodgkin Lymphoma Market Size & Forecast
6.3. France Non-Hodgkin Lymphoma Product Sales Forecast
6.4. France Non-Hodgkin Lymphoma Market Share Analysis

7. Italy Non-Hodgkin Lymphoma Market Insights
7.1. Marketed Drugs for Non-Hodgkin Lymphoma in Italy
7.2. Italy Non-Hodgkin Lymphoma Market Size & Forecast
7.3. Italy Non-Hodgkin Lymphoma Product Sales Forecast
7.4. Italy Non-Hodgkin Lymphoma Market Share Analysis

8. Spain Non-Hodgkin Lymphoma Market Insights
8.1. Marketed Drugs for Non-Hodgkin Lymphoma in Spain
8.2. Spain Non-Hodgkin Lymphoma Market Size & Forecast
8.3. Spain Non-Hodgkin Lymphoma Product Sales Forecast
8.4. Spain Non-Hodgkin Lymphoma Market Share Analysis

9. UK Non-Hodgkin Lymphoma Market Insights
9.1. Marketed Drugs for Non-Hodgkin Lymphoma in UK
9.2. UK Non-Hodgkin Lymphoma Market Size & Forecast
9.3. UK Non-Hodgkin Lymphoma Product Sales Forecast
9.4. UK Non-Hodgkin Lymphoma Market Share Analysis

10. Europe Non-Hodgkin Lymphoma Market Insights
10.1. Europe Non-Hodgkin Lymphoma Market Size & Forecast
10.2. Europe Non-Hodgkin Lymphoma Product Sales Forecast
10.3. Europe Non-Hodgkin Lymphoma Market Share Analysis

11. Japan Non-Hodgkin Lymphoma Market Insights
11.1. Marketed Drugs for Non-Hodgkin Lymphoma in Japan
11.2. Japan Non-Hodgkin Lymphoma Market Size & Forecast
11.3. Japan Non-Hodgkin Lymphoma Product Sales Forecast
11.4. Japan Non-Hodgkin Lymphoma Market Share Analysis

12. Global Non-Hodgkin Lymphoma Market Insights
12.1. Global Non-Hodgkin Lymphoma Market Size & Forecast
12.2. Global Non-Hodgkin Lymphoma Product Sales Forecast
12.3. Global Non-Hodgkin Lymphoma Market Share Analysis

13. Research Methodology

List of Tables
Table 1: Non-Hodgkin Lymphoma Phase 3 Clinical Trials, Global, 2020
Table 2: Non-Hodgkin Lymphoma Phase 2 Clinical Trials, Global, 2020
Table 3: Non-Hodgkin Lymphoma Phase 1 Clinical Trials, Global, 2020
Table 4: Non-Hodgkin Lymphoma Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Non-Hodgkin Lymphoma in US, 2019
Table 6: US Non-Hodgkin Lymphoma Market Size & Forecast ($mn), 2016 - 2024
Table 7: US Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Table 8: US Non-Hodgkin Lymphoma Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Non-Hodgkin Lymphoma in Germany, 2019
Table 10: Germany Non-Hodgkin Lymphoma Market Size & Forecast ($mn), 2016 - 2024
Table 11: Germany Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Table 12: Germany Non-Hodgkin Lymphoma Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Non-Hodgkin Lymphoma in France, 2019
Table 14: France Non-Hodgkin Lymphoma Market Size & Forecast ($mn), 2016 - 2024
Table 15: France Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Table 16: France Non-Hodgkin Lymphoma Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Non-Hodgkin Lymphoma in Italy, 2019
Table 18: Italy Non-Hodgkin Lymphoma Market Size & Forecast ($mn), 2016 - 2024
Table 19: Italy Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Table 20: Italy Non-Hodgkin Lymphoma Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Non-Hodgkin Lymphoma in Spain, 2019
Table 22: Spain Non-Hodgkin Lymphoma Market Size & Forecast ($mn), 2016 - 2024
Table 23: Spain Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Table 24: Spain Non-Hodgkin Lymphoma Market Events and Trends, 2016 - 2024
Table 25: Marketed Drugs for Non-Hodgkin Lymphoma in UK, 2019
Table 26: UK Non-Hodgkin Lymphoma Market Size & Forecast ($mn), 2016 - 2024
Table 27: UK Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Table 28: UK Non-Hodgkin Lymphoma Market Events and Trends, 2016 - 2024
Table 29: Europe Non-Hodgkin Lymphoma Market Size & Forecast ($mn), 2016 - 2024
Table 30: Europe Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Table 31: Marketed Drugs for Non-Hodgkin Lymphoma in Japan, 2019
Table 32: Japan Non-Hodgkin Lymphoma Market Size & Forecast ($mn), 2016 - 2024
Table 33: Japan Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Table 34: Japan Non-Hodgkin Lymphoma Market Events and Trends, 2016 - 2024
Table 35: Global Non-Hodgkin Lymphoma Market Size & Forecast ($mn), 2016 - 2024
Table 36: Global Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Non-Hodgkin Lymphoma Pipeline by Phase (%), Global, 2020
Figure 2: Non-Hodgkin Lymphoma Prevalence by Countries, 2016 - 2024
Figure 3: US Non-Hodgkin Lymphoma Market Size ($mn), 2016 - 2024
Figure 4: US Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Figure 5: US Non-Hodgkin Lymphoma Market Share by Drugs (%), 2019
Figure 6: US Non-Hodgkin Lymphoma Market - Future Market Share (%), 2024
Figure 7: Germany Non-Hodgkin Lymphoma Market Size ($mn), 2016 - 2024
Figure 8: Germany Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Figure 9: Germany Non-Hodgkin Lymphoma Market Share by Drugs (%), 2019
Figure 10: Germany Non-Hodgkin Lymphoma Market - Future Market Share (%), 2024
Figure 11: France Non-Hodgkin Lymphoma Market Size ($mn), 2016 - 2024
Figure 12: France Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Figure 13: France Non-Hodgkin Lymphoma Market Share by Drugs (%), 2019
Figure 14: France Non-Hodgkin Lymphoma Market - Future Market Share (%), 2024
Figure 15: Italy Non-Hodgkin Lymphoma Market Size ($mn), 2016 - 2024
Figure 16: Italy Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Figure 17: Italy Non-Hodgkin Lymphoma Market Share by Drugs (%), 2019
Figure 18: Italy Non-Hodgkin Lymphoma Market - Future Market Share (%), 2024
Figure 19: Spain Non-Hodgkin Lymphoma Market Size ($mn), 2016 - 2024
Figure 20: Spain Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Figure 21: Spain Non-Hodgkin Lymphoma Market Share by Drugs (%), 2019
Figure 22: Spain Non-Hodgkin Lymphoma Market - Future Market Share (%), 2024
Figure 23: UK Non-Hodgkin Lymphoma Market Size ($mn), 2016 - 2024
Figure 24: UK Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Figure 25: UK Non-Hodgkin Lymphoma Market Share by Drugs (%), 2019
Figure 26: UK Non-Hodgkin Lymphoma Market - Future Market Share (%), 2024
Figure 27: Europe Non-Hodgkin Lymphoma Market Size ($mn), 2016 - 2024
Figure 28: Europe Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Figure 29: Europe Non-Hodgkin Lymphoma Market Share by Drugs (%), 2019
Figure 30: Europe Non-Hodgkin Lymphoma Market - Future Market Share (%), 2024
Figure 31: Japan Non-Hodgkin Lymphoma Market Size ($mn), 2016 - 2024
Figure 32: Japan Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Figure 33: Japan Non-Hodgkin Lymphoma Market Share by Drugs (%), 2019
Figure 34: Japan Non-Hodgkin Lymphoma Market - Future Market Share (%), 2024
Figure 35: Global Non-Hodgkin Lymphoma Market Size ($mn), 2016 - 2024
Figure 36: Global Non-Hodgkin Lymphoma Product Sales ($mn), 2016 - 2024
Figure 37: Global Non-Hodgkin Lymphoma Market Share by Drugs (%), 2019
Figure 38: Global Non-Hodgkin Lymphoma Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll